Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001683168-24-000159)

Filing Details

Accession Number:: 0001683168-24-000159
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-09 17:30:55
Reporting Period:: 2024-01-05

Accepted Time:: 2024-01-09 17:30:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759186	Coeptis Therapeutics Holdings Inc.	COEP	Biological Products, (No Disgnostic Substances) (2836)	981465952

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1846623	David Mehalick	105 Bradford Rd, Suite 420 Wexford PA 15090	Ceo And President	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-01-05	5,050	$0.69	2,762,611	No	4	P	Direct
Common Stock	Acquisiton	2024-01-08	6,000	$0.67	2,768,611	No	4	P	Direct
Common Stock	Acquisiton	2024-01-08	14,004	$0.66	2,782,615	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days.